Medicity Daegu

Medicity Daegu

Home IntroductionMedicity Daegu
Medical Capotal of Korea, Medi city Daegu

Medicity Daegu, the Medical Capital of Korea Welcomes you to Medicity Daegu

Medicity is a brand that represents Daegu’s superior medical services and aims to develop and globalize the medical technologies and services of Korea through the development of the hospital service industry, convergence of medical industries, and successful establishment of a medical innovation complex.

Medicity Daegu, the Heart of Daegu Metropolitan City

Boasting six major medical training institutions, over 3,200 medical institutions, and a medical workforce of over 27,000, Daegu is renowned for its active research on difficult-to-cure diseases and world-class medical treatments.
With the easy access to the Daegu-Gyeongbuk Medical Cluster and Suseong Medical Zone, Daegu is inarguably the heart of cutting-edge medicine and medical infrastructure in Korea.

Medical Infrastructure

  • Medical Education Institutions4 medical universities, 1 Oriental Medicine University, 1 Graduate School of Dentistry
  • Medical Institutions3,200 institutions including 12 general hospitals, 1,700 hospitals and clinics, 700 dental clinics, and 800 oriental medicine clinics
  • Medical Personnel27,000 medical professionals including 5,000 medical doctors, 1,000 doctors of dental surgery, 900 doctors of oriental medicine, 7,800 nurses, and 13,000 other staff members

Hospitals

Major hospitals in Daegu providing medical services in foreign languages
JCI-accredited Hospitals in Daegu
  • Kyungpook National University Hospital Health Promotion Center
    Tel
    +82 53-200-6060
    Website
    Website Go
  • AllforSkin Dermatology Clinic
    Tel
    +82 53-425-7582
    Website
    Website Go
  • Dukyoung Dental Hospital
    Tel
    +82 53-256-2145
    Website
    Website Go
  • Mir Dental Hospital
    Tel
    +82 53-212-1000
    Website
    Website Go
  • EFIL Plastic Surgery Clinic
    Tel
    +82 53-253-9977
    Website
    Website Go

Joint Commission International(JCI) accreditation represents that the medical services provided by a hospital are equivalent in quality and patient safety to medical services internationally.

Medivalley

Medivalley is a high-tech medical industrial complex established by the national government for the purpose of developing the national medical industry into a leading industry worldwide. The project, which began in 2009 and is scheduled for completion in 2038, has a total budget of USD $4.6 billion and was assigned to an area of 1.05 million square meters in Daegu Innovation City, Dong-gu by the Daegu Metropolitan Government in August 2009. Medivalley aims to develop 16 new pharmaceutical drugs and 18 high-tech medical devices and introduce them to the world market.

Groundbreaking for Medivalley officially took place in October 2011, followed by the completion of four key research support centers—the Drug Development Support Center, Medical Device Development Support Center, Laboratory Animal Center, and Clinical Trial Materials Manufacturing Center—in November 2013. Starting from 2014, Medivalley has been involved in full-scale research and development activities and the attraction of anchor businesses to the complex.

In the last few years, Medivalley has welcomed the Korea Brain Research Institute, KM Application Center, and the 3D Convergence Technology Support Center, which were completed in Dec 2014, June 2015, and September 2015 respectively. Eight more institutions that will soon join Medivalley as the result of construction or relocation include the: High-tech Medical Genome Research Institute, Laboratory Animal Resources Bank, High-tech Clinical Trial Center, K-Medical Center, Medical Technology Testing & Training Institute, ICT Clinical Trial Support Center, Medical Device SW Testing & Certification Center, and Ministry of Food and Drug Safety Daegu Office.

As of the end of 2015, a total of 98 companies are scheduled to move into the Medivalley area, including 43 companies—34 medical device, 8 pharmaceutical & biotechnology, and 1 other company—in the Medivalley research complex, and 55 companies—52 medical device, 2 pharmaceutical & biotechnology, and 1 medical information company—in the INNOPOLIS Daegu Medical R&D District.

In 2016, Medivalley plans to welcome the National Heart Center, the Center for Inter-Industry Collaboration, and the Academic Research Institute. Preparations are also being made for government-led feasibility studies on the establishment of a high-tech brain research cluster and a national bio-imaging center as well as a modular-based medical devices platform development project.

Top